Landauer Inc. (LDR) Downgraded by Zacks Investment Research
According to Zacks, “Landauer Inc. is the world’s leading provider of analytical services to determine occupational and environmental radiation exposure. For more than fifty years, the company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings. The company provides its services to one.five million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia and other countries. “
Other equities research analysts also recently issued reports about the company. Hilliard Lyons downgraded Landauer from a neutral rating to an underperform rating in a report on Friday, July 1st. Sidoti downgraded Landauer from a buy rating to a neutral rating and set a $52.00 price target for the company. in a report on Tuesday, August 16th.
Shares of Landauer (NYSE:LDR) opened at 43.97 on Tuesday. Landauer has a 12-month low of $26.99 and a 12-month high of $49.74. The firm has a 50-day moving average price of $45.29 and a 200-day moving average price of $40.66. The firm has a market cap of $422.24 million, a P/E ratio of 23.77 and a beta of 1.08.
Landauer (NYSE:LDR) last announced its earnings results on Monday, August 8th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.19. Landauer had a return on equity of 102.93% and a net margin of 11.63%. The company had revenue of $37.90 million for the quarter, compared to analyst estimates of $35.24 million. On average, equities research analysts expect that Landauer will post $1.76 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, October 5th. Stockholders of record on Friday, September 16th were issued a $0.275 dividend. The ex-dividend date of this dividend was Wednesday, September 14th. This represents a $1.10 dividend on an annualized basis and a dividend yield of 2.50%. Landauer’s dividend payout ratio (DPR) is 59.14%.
Large investors have recently modified their holdings of the stock. Guggenheim Capital LLC increased its stake in shares of Landauer by 0.3% in the second quarter. Guggenheim Capital LLC now owns 8,815 shares of the company’s stock worth $363,000 after buying an additional 29 shares during the period. Suntrust Banks Inc. increased its position in shares of Landauer by 0.5% in the second quarter. Suntrust Banks Inc. now owns 37,000 shares of the company’s stock worth $1,522,000 after buying an additional 200 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of Landauer by 5.7% in the second quarter. PNC Financial Services Group Inc. now owns 5,730 shares of the company’s stock worth $235,000 after buying an additional 309 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Landauer by 0.6% in the first quarter. Geode Capital Management LLC now owns 63,911 shares of the company’s stock worth $2,113,000 after buying an additional 364 shares during the last quarter. Finally, Prudential Financial Inc. increased its position in shares of Landauer by 1.7% in the second quarter. Prudential Financial Inc. now owns 23,504 shares of the company’s stock worth $967,000 after buying an additional 400 shares during the last quarter. Institutional investors and hedge funds own 86.34% of the company’s stock.
Landauer Company Profile
Landauer, Inc (Landauer) is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a domestic provider of outsourced medical physics services and a provider of radiology related medical products. It operates in three business segments: Radiation Measurement, Medical Physics and Medical Products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.